Literature DB >> 7523215

Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis.

M Hartleb1, R Moreau, S Cailmail, C Gaudin, D Lebrec.   

Abstract

BACKGROUND/AIMS: Because the vasodilator nitric oxide is overproduced in cirrhosis, this substance may decrease pressor responses to the vasoconstrictor endothelin 1. This study aimed to examine the effects of a NO synthesis inhibitor (NG-nitro-L-arginine methyl ester; L-NAME) on vascular responsiveness to endothelin 1 in normal and cirrhotic rats.
METHODS: Pressor dose-response curves to endothelin 1 (0.5, 1, 3, 6, and 10 micrograms/kg intravenously) were obtained in animals with or without pretreatment with L-NAME.
RESULTS: Pressor responses to endothelin 1 alone were significantly lower in cirrhotic than in normal rats. In cirrhotic animals, pressor responses to 3, 6, and 10 micrograms/kg of endothelin 1 were significantly higher in the presence than in the absence of L-NAME. The responses to the other doses of endothelin 1 were not affected by L-NAME. In normal rats, pressor responses to all doses of endothelin 1 were significantly higher in the presence than in the absence of L-NAME. In animals pretreated with L-NAME, pressor responses to 6 and 10 micrograms/kg of endothelin 1 did not differ between cirrhotic and normal rats, whereas responses to other doses remained lower in cirrhotic than in normal rats.
CONCLUSIONS: In rats with cirrhosis, NO seems to contribute to vascular hyporeactivity to high doses but not to low doses of endothelin 1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523215     DOI: 10.1016/0016-5085(94)90233-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

Review 1.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Authors:  Francesco Salerno; Alexander Gerbes; Pere Ginès; Florence Wong; Vicente Arroyo
Journal:  Gut       Date:  2007-03-27       Impact factor: 23.059

2.  ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.

Authors:  Kai Y Mak; Ruth Chin; Sharon C Cunningham; Miriam R Habib; Joseph Torresi; Alexandra F Sharland; Ian E Alexander; Peter W Angus; Chandana B Herath
Journal:  Mol Ther       Date:  2015-05-25       Impact factor: 11.454

3.  Murine study of portal hypertension associated endothelin-1 hypo-response.

Authors:  Nicholas Theodorakis; Mary Maluccio; Nicholas Skill
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

4.  Acute effect of low dose theophylline on the circulatory disturbances of cirrhosis.

Authors:  E H Forrest; I A Bouchier; P C Hayes
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

5.  Bile acids increase intracellular Ca(2+) concentration and nitric oxide production in vascular endothelial cells.

Authors:  T Nakajima; Y Okuda; K Chisaki; W S Shin; K Iwasawa; T Morita; A Matsumoto; J I Suzuki; S Suzuki; N Yamada; T Toyo-Oka; R Nagai; M Omata
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

6.  Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.

Authors:  P Y Martin; M Ohara; P Gines; D L Xu; J St John; M Niederberger; R W Schrier
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 7.  Nitric oxide and portal hypertension.

Authors:  Juan González-Abraldes; Juan Carlos García-Pagán; Jaime Bosch
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

8.  Therapeutic potential of targeting the renin angiotensin system in portal hypertension.

Authors:  Chandana B Herath; Josephine A Grace; Peter W Angus
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15

9.  Increased sinusoidal resistance is responsible for the basal state and endothelin-induced venoconstriction in perfused cirrhotic rat liver.

Authors:  Toshishige Shibamoto; Chiaki Kamikado; Shozo Koyama
Journal:  Pflugers Arch       Date:  2008-01-05       Impact factor: 3.657

10.  Vascular actions of peripheral CGRP in migraine-like photophobia in mice.

Authors:  Bianca N Mason; Anne-Sophie Wattiez; Louis K Balcziak; Adisa Kuburas; William J Kutschke; Andrew F Russo
Journal:  Cephalalgia       Date:  2020-08-18       Impact factor: 6.292

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.